Back to search
Treatment-resistant Schizophrenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment-resistant Schizophrenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment-resistant Schizophrenia trials you may qualify forThis observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psyc…
This is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
This is a prospective, 12-week, randomized, double-blind, placebo-controlled study, designed to evaluate the efficacy, safety, and tolerability of a dose of eve…
Previous study found that some NMDA-enhancing agent was able to augment efficacy of clozapine for clinical symptoms but not cognitive function in the treatment…
The purpose of this pilot study is to investigate the use of deep brain stimulation (DBS) of the substantia nigra pars reticulata (SNr) in subjects with treatme…
Schizophrenia is one of the most severe and costliest mental disorders in terms of human suffering and societal expenditure. About 15-30% of patients do not res…
The purpose of the study is to compare the effectiveness of stimulation of the left precuneus by intermittent Theta Burst Stimulation to placebo stimulation on…
The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- res…